Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|13|5|656-662

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.13, Iss.5, 2015-09, pp. : 656-662

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Approaches for Treatment-resistant Bipolar Disorder

By  

Current Neuropharmacology, Vol. 13, Iss. 5, 2015-09 ,pp. : 592-604

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder

By Abudy Anat   Juven-Wetzler Alzbeta   Zohar Joseph  

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 585-596

Adis International

Access to resources Recommend Favorite

Pramipexole is a useful adjunct to mood-stabilising therapy in treatment-resistant bipolar depression

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Sequential administration of augmentation strategies in treatment-resistant obsessive compulsive disorder

By Blier P.   Bergeron R.   Heacute bert C.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 370-370

Elsevier

Access to resources Recommend Favorite

Combination of ''atypical'' antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder

By Lerner V.   Libov I.   Kotler M.   Strous R.D.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. : 89-98

Elsevier

Access to resources Recommend Favorite